Overweight

Patients who were obese, overweight or underweight were at an increased risk for AKI, compared with patients who had a normal BMI, according to data published in the Journal of Renal Nutrition.

Both exercise and caloric restriction reduced visceral adipose tissue among adults with overweight and obesity, but only exercise had a dose-dependent effect, according to researchers.

The effect of vitamin D supplementation on total 25-hydroxyvitamin D levels may be blunted for adults with a higher BMI, according to a post hoc analysis of data from the VITAL trial.

With a lack of well-defined guidelines, many primary care providers in the United Kingdom provided generic weight-loss advice to patients with obesity, a recent study found.

Results from a meta-analysis underscored the need to improve understanding of nonalcoholic fatty liver disease burden and management in at-risk individuals who are overweight and obese.

The AGA has released its first guideline endorsing the use of four medications for obesity management, when paired with lifestyle interventions, for patients who have failed to lose weight with diet and exercise alone.

After transcatheter aortic valve replacement, patients with BMI more than 25 kg/m2 had less all-cause mortality, aortic regurgitation and MI compared with those under that threshold, according to a meta-analysis.

Ultraprocessed food intake among mothers was associated with an increased risk for overweight and obesity among their children, according to researchers.

Today, Eli Lilly and Company received FDA fast track designation for tirzepatide to treat adults with obesity or overweight with weight-related comorbidities.

In real-world data from adults with overweight or obesity, weekly semaglutide therapy of 1.7 mg or 2.4 mg was effective at 3 and 6 months for weight loss amounts similar to those observed in clinical trials, according to researchers.